A randomized cross-over trial on the direct effects of oxygen supplementation therapy using different devices on cycle endurance in hypoxemic patients with Interstitial Lung Disease.

<h4>Background</h4>In patients with interstitial lung disease (ILD) a cardinal feature is exercise intolerance, often associated with significant dyspnea and severe hypoxemia. Supplemental oxygen therapy may be offered during exercise. The Oxymizer is a nasal cannula with an incorporated...

Full description

Bibliographic Details
Main Authors: Anne Edvardsen, Inga Jarosch, Anita Grongstad, Laura Wiegand, Rainer Gloeckl, Klaus Kenn, Martijn A Spruit
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0209069